CAS RN: 1193372-03-0
MIL-125(Ti)
Product Availability
Choose a grade to view its available package options.
4 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260323 |
100mg / 250mg / 1g |
Confirm by inquiry |
Shanghai | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251203 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260217 |
1g |
In stock |
Shanghai | Inquiry |
| Batchno.20260306 |
250mg |
In stock |
Shanghai | Inquiry |
-
Product code:
starshine_CAS1193372-03-0
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1193372-03-0 / octakis(oxygen(2-));terephthalate;octakis(titanium(4+));tetrahydroxide
CID 160315322 | SUCROSE PHOSPHORYLASE | Bucelipase alfa
Standard CAS: 1193372-03-0
Multi CAS: Yes
Basic Information
CAS
1193372-03-0
Multi CAS
Yes
Molecular Formula
C48H28O36Ti8
Molecular Weight
1563.600000
Exact Mass
1563.619553
SMILES
C1=CC(=CC=C1C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C(=O)[O-])C(=O)[O-].C1=CC(=CC=C1C(=O)[O-])C(=O)[O-].[OH-].[OH-].[OH-].[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4].[Ti+4]
InChI
InChI=1S/6C8H6O4.4H2O.8O.8Ti/c6*9-7(10)5-1-2-6(4-3-5)8(11)12;;;;;;;;;;;;;;;;;;;;/h6*1-4H,(H,9,10)(H,11,12);4*1H2;;;;;;;;;;;;;;;;/q;;;;;;;;;;8*-2;8*+4/p-16
InChIKey
UOOFDWNDJVPECW-UHFFFAOYSA-A
Synonyms
CID 160315322
SUCROSE PHOSPHORYLASE
Bucelipase alfa
Luciferase from Vibrio fischeri (Photobacterium f)
DA-75147
Computed Properties
Structural Parameters
Heavy atom count
92
Aromatic heavy atom count
36
Rotatable bonds
12
H-bond acceptors
28
H-bond donors
4
Molar refractivity
223.85
TPSA
829.56
LogP / Solubility
WLOGP
-11.2
MLOGP
-9.69
XLogP3
-11.2
Consensus LogP
-10.7
Log S (ESOL)
-1.98
Class (ESOL)
Soluble
Log S (Ali)
-4.3
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-1.97
Class (SILICOS-IT)
Soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-20.21
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5.5